Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1142

    1.

    Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.

    Tuomi T, Honkanen EH, Isomaa B, Sarelin L, Groop LC.

    Diabetes Care. 2006 Feb;29(2):189-94.PMID: 16443858 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A placebo-controlled crossover study comparing the effects of nateglinide and glibenclamide on postprandial hyperglycaemia and hyperinsulinaemia in patients with type 2 diabetes.

    Barnett AH, Anderson DM, Shelley S, Morgan R, Owens DR.

    Diabetes Obes Metab. 2004 Mar;6(2):104-13.PMID: 14746575 [PubMed - indexed for MEDLINE]Related articles

    3.

    Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166).

    Gribble FM, Manley SE, Levy JC.

    Diabetes Care. 2001 Jul;24(7):1221-5.PMID: 11423506 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.

    Derosa G, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Cicero AF.

    J Clin Pharm Ther. 2009 Feb;34(1):13-23.PMID: 19125899 [PubMed - indexed for MEDLINE]Related articles

    5.

    Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.

    Hollander PA, Schwartz SL, Gatlin MR, Haas SJ, Zheng H, Foley JE, Dunning BE.

    Diabetes Care. 2001 Jun;24(6):983-8.PMID: 11375357 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.

    Vakkilainen J, Mero N, Schweizer A, Foley JE, Taskinen MR.

    Diabetes Metab Res Rev. 2002 Nov-Dec;18(6):484-90.PMID: 12469362 [PubMed - indexed for MEDLINE]Related articles

    7.

    Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

    Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

    Diabetes Care. 2002 Dec;25(12):2147-52.PMID: 12453952 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis.

    Tentolouris N, Boutati E, Karambakalis N, Perrea D, Tselepis AD, Tsoukala C, Kyriaki D, Lourida E, Anastasopoulou I, Karafoullidou A, Raptis SA, Katsilambros N.

    Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):6-12. Erratum in: Nutr Metab Cardiovasc Dis. 2006 Jan;16(1):81. Perea, D [corrected to Perrea, D]. PMID: 15871845 [PubMed - indexed for MEDLINE]Related articles

    10.

    Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.

    Hanefeld M, Bouter KP, Dickinson S, Guitard C.

    Diabetes Care. 2000 Feb;23(2):202-7.PMID: 10868832 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus.

    Fonseca VA, Kelley DE, Cefalu W, Baron MA, Purkayastha D, Nestler JE, Hsia S, Gerich JE.

    Metabolism. 2004 Oct;53(10):1331-5. Erratum in: Metabolism. 2005 May;54(5):698. PMID: 15375790 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus.

    Malaisse WJ.

    Treat Endocrinol. 2003;2(6):401-14. Review.PMID: 15981944 [PubMed - indexed for MEDLINE]Related articles

    13.

    Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

    Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S.

    Diabetes Care. 2000 Nov;23(11):1660-5.PMID: 11092289 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin.

    Hirschberg Y, Karara AH, Pietri AO, McLeod JF.

    Diabetes Care. 2000 Mar;23(3):349-53.PMID: 10868864 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients.

    Voytovich MH, Haukereid C, Hjelmesaeth J, Hartmann A, Løvik A, Jenssen T.

    Clin Transplant. 2007 Mar-Apr;21(2):246-51.PMID: 17425753 [PubMed - indexed for MEDLINE]Related articles

    16.

    Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population.

    Saloranta C, Guitard C, Pecher E, De Pablos-Velasco P, Lahti K, Brunel P, Groop L.

    Diabetes Care. 2002 Dec;25(12):2141-6.PMID: 12453951 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trial.

    Derosa G, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Cicero AF.

    Intern Med. 2007;46(22):1837-46. Epub 2007 Nov 16.PMID: 18025765 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control.

    Fonseca V, Grunberger G, Gupta S, Shen S, Foley JE.

    Diabetes Care. 2003 Jun;26(6):1685-90.PMID: 12766094 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Mealtime glucose regulation with nateglinide in healthy volunteers: comparison with repaglinide and placebo.

    Kalbag JB, Walter YH, Nedelman JR, McLeod JF.

    Diabetes Care. 2001 Jan;24(1):73-7.PMID: 11194245 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus.

    Keilson L, Mather S, Walter YH, Subramanian S, McLeod JF.

    J Clin Endocrinol Metab. 2000 Mar;85(3):1081-6.PMID: 10720043 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data